Tandem Diabetes Care Inc (TNDM) stock saw a modest uptick, ending the day at $45.42 which represents a slight increase of $0.79 or 1.77% from the prior close of $44.63. The stock opened at $45.17 and ...
Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for ...
The t:slim X2 pump is currently cleared for use with Humalog and Novolog/NovoRapid U-100 insulins globally, and Admelog/Insulin lispro Sanofi and Trurapi/Insulin aspart Sanofi U-100 insulins in Canada ...
Headlines,Tandem Diabetes Care shares saw a significant rise after a crucial EU approval for its insulin delivery system.,The ...
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback